Thomas Trimarchi
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
-
- Acute Myeloid Leukemia Research 6
- Co-authors
- Iannis AifantisPanagiotis NtziachristosAristotelis TsirigosErhan BilalRiccardo Dalla‐FaveraGiulia FabbriBryan H. KingJasper Mullenders
- Journals
- Cancer Cell (3 papers)Cell (2 papers)Nature Cell Biology (2 papers)Nature Medicine (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaAustria
In The Last Decade
Thomas Trimarchi
20 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 86
- Hematology 394
- Cancer Research 528
- Molecular Biology 1.4k
- Immunology 314
- Oncology 392
Countries citing papers authored by Thomas Trimarchi
This map shows the geographic impact of Thomas Trimarchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Trimarchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Trimarchi more than expected).
Fields of papers citing papers by Thomas Trimarchi
This network shows the impact of papers produced by Thomas Trimarchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Trimarchi. The network helps show where Thomas Trimarchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Trimarchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 58 | |
| 2 | 2017 | 23 | |
| 3 | 2016 | 54 | |
| 4 | 2016 | 27 | |
| 5 | 2015 | 170 | |
| 6 | 2015 | 2 | |
| 7 | 2015 | 24 | |
| 8 | 2015 | 190 | |
| 9 | 2015 | 125 | |
| 10 | 2014 | 340 | |
| 11 | 2013 | 27 | |
| 12 | 2013 | 252 | |
| 13 | 2012 | 48 | |
| 14 | 2012 | 142 | |
| 15 | 2011 | 271 | |
| 16 | 2010 | 214 | |
| 17 | 2009 | 18 | |
| 18 | 2008 | 19 | |
| 19 | 2008 | 12 | |
| 20 | 2008 | 4 |
About Thomas Trimarchi
Thomas Trimarchi is a scholar working on Hematology, Developmental Neuroscience, Immunology, Cancer Research and Critical Care and Intensive Care Medicine, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Immune Cell Function and Interaction (3 papers), RNA modifications and cancer (3 papers), Acute Lymphoblastic Leukemia research (3 papers), T-cell and Retrovirus Studies (2 papers), Pluripotent Stem Cells Research (2 papers), CAR-T cell therapy research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Hematology (394 citations), Cancer Research (528 citations), Molecular Biology (1.4k citations), Immunology (314 citations) and Oncology (392 citations). Thomas Trimarchi has collaborated with scholars based in United States, Australia and Austria. Frequent co-authors include Iannis Aifantis, Panagiotis Ntziachristos, Aristotelis Tsirigos, Erhan Bilal, Riccardo Dalla‐Favera, Giulia Fabbri, Bryan H. King, Jasper Mullenders, Adolfo A. Ferrando and Beatriz Aranda-Orgillés. Their work appears in journals such as Cancer Cell, Cell, Nature Cell Biology, Nature Medicine and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.